The rise of Sildenafil initially drove significant growth in the pharmaceutical sector, creating a understanding of guaranteed returns. However, placing capital in companies primarily reliant on flagship drugs like https://arontkzk606839.ja-blog.com/41405763/the-blue-pill-and-big-pharma-a-hazardous-investment